Bień Stanisław, Okła Sławomir
Dział Otolaryngologii Chirurgii Głowy i Szyi Swietokrzyskiego Centrum Onkologii w Kielcach.
Otolaryngol Pol. 2006;60(2):129-34.
Surgical rehabilitation of voice and speech, with implantation of Provox 2 voice prosthesis is becoming a standard procedure in Poland in the last few years. Still some opinions are raised, considering the potential risk of complications, particularly, when tracheo-esophageal puncture is finally located in the irradiated tissue.
The assessment of safety, and analysis of complication encountered with tracheo-esophageal puncture, and implantation of voice prosthesis.
The 106 cases of patients treated with mentioned above method. The primary implantation was performed in 73 (68,9%) cases; the secondary implantation in 33 (31,1%). The 85 (80,2%) patients received radiotherapy before, or after implantation. In the analyzed period (2002-2004) apart of 106 implantations, the replacement of 132 prostheses was performed.
There was only one, potentially life-threatening complication recorded in the analyzed group of 106 patients--inhalation of prosthesis to tracheo-bronchial tree. The most common complications directly related to implantation were: infection in the place of created fistula after secondary implantation 4/33(12,1%), and spontaneous partial extrusion of prosthesis with occlusion of created fistula tract 8/106 (7,5%). The average lifetime of prosthesis in place, was 9,8 months in irradiated field, and 9,7 months in patients who did not received radiotherapy.
Surgical rehabilitation of voice and speech, with implantation of vocal prosthesis is safe and reliable procedure. The radiotherapy applied before or after creation of tracheo-esophageal fistula is not a contra indication for this method. Generally low rate of complications is similar in both groups--who does received or not received radiotherapy. Also the stability of implanted prostheses were similar in both groups.
在过去几年中,植入Provox 2语音假体进行嗓音和言语的外科康复在波兰正成为一种标准手术。然而,考虑到并发症的潜在风险,尤其是当气管食管穿刺最终位于受照射组织中时,仍有一些不同意见。
评估气管食管穿刺及语音假体植入的安全性,并分析所遇到的并发症。
106例采用上述方法治疗的患者。73例(68.9%)进行了初次植入;33例(31.1%)进行了二次植入。85例(80.2%)患者在植入前或植入后接受了放疗。在分析期间(2002 - 2004年),除了106例植入手术外,还进行了132次假体更换。
在106例分析患者组中仅记录到1例潜在危及生命的并发症——假体吸入气管支气管树。与植入直接相关的最常见并发症为:二次植入后造瘘部位感染4/33(12.1%),以及假体自发部分脱出并阻塞造瘘通道8/106(7.5%)。在受照射区域,假体在位的平均寿命为9.8个月,未接受放疗的患者为9.7个月。
植入语音假体进行嗓音和言语的外科康复是一种安全可靠的手术。在气管食管瘘形成之前或之后进行放疗并非该方法的禁忌证。总体而言,两组(接受或未接受放疗)的并发症发生率都较低,且植入假体的稳定性在两组中相似。